Precision is paramount in pharmaceutical manufacturing. It impacts drug efficacy and patient safety while ensuring companies adhere to regulatory compliance.
X-ray fluorescence (XRF) is one of many tools pharmaceutical companies use to enhance accuracy and quality control during drug production. This technology detects, quantifies, and analyses inorganic impurities.
There are several applications of XRF in pharmaceuticals manufacturing. It screens raw materials for toxins such as lead or mercury and checks final products for quality. XRF also reduces the need for costly laboratory analysis.
As demand for specialised drugs rises, XRF is an invaluable tool for efficient production and compliance.
In this post:
Key Takeaways
X-ray fluorescence spectroscopy supports the non-destructive testing of raw materials used in pharmaceutical manufacturing
XRF delivers precise elemental analysis to detect levels of toxic trace metals and impurities found in Active Pharmaceutical Ingredients (APIs) and inactive materials
XRF plays a vital role in the drug formulation process, ensuring quality, consistency, safety, and drug efficacy
Regulatory compliance is one of the most important applications of XRF in pharmaceuticals manufacturing
X-Ray Fluorescence Spectroscopy
Pharmaceutical manufacturing involves various spectroscopic techniques for product analysis. XRF spectroscopy is becoming increasingly popular as an alternative to traditional laboratory screening.
The process involves shooting a drug sample with high-energy X-rays. This destabilises atoms by knocking inner-level electrons out.
Higher-level electrons quickly restabilise the atom by filling the empty spots. In doing so, they release a burst of energy in the form of an X-ray. This burst of energy is unique to the electron’s elemental makeup. Think of it like a fluorescent fingerprint.
X-ray fluorescence spectroscopy offers several benefits:
- It’s non-destructive, allowing manufacturers to reuse APIs.
- It provides results in as little as 30 minutes, speeding the manufacturing and quality control process.
- It doesn’t require the use of harmful acids or gases.
- It can analyse packing materials for toxic substances.
- It supports regulatory compliance by detecting toxic elements, improving the chance of a drug’s approval.
Companies can harness these benefits by integrating different applications of XRF in pharmaceuticals manufacturing.
XRF for Elemental Analysis
Drug quality, consistency, and safety depend on stringent elemental analysis and testing. XRF makes this process fast and easy.
For pharmaceutical manufacturers, knowing the elemental composition of raw materials, APIs, and excipients (inactive substances) is imperative. It ensures drug purity and reduces the chance of harmful trace metals or residual chemical reagents ending up in final products.
Detecting and analysing trace quantities of impurities or elements if an API is challenging. These materials can present at levels as small as parts-per-billion (ppb) or have chemical structures similar to the API.
Using XRF imaging for elemental analysis provides a reliable solution to these challenges, allowing companies to produce quality drugs at high volumes.
Toxic Metal Detection
Noble metals like palladium and platinum are often required during API synthesis. X-ray fluorescence can detect them at parts-per-million, so they can be removed before batch production.
XRF also screens for toxic heavy metals like lead or arsenic that make their way into drug formulations from raw materials or leaching from manufacturing equipment. Early detection allows for the removal of heavy metals before production.
Raw Material Analysis
Drugs contain a wide range of raw materials, from APIs and binders to biological buffers that regulate pH levels. All of these raw materials must be tested for purity.
XRF facilitates rapid testing of incoming raw materials, detecting impurities, and ensuring the consistency of all necessary components. It also spots elemental discrepancies common in counterfeit drugs.
Liquid Analysis
Impurities in water or solvents can compromise the quality of a drug. X-ray fluorescence spectroscopy detects these impurities at extremely low levels.
Traditional instruments like Inductively Coupled Plasma Spectrometry require acids to digest drug samples before testing. XRF can test liquids right away, speeding the quality assurance process.
The Role of XRF in Drug Formulation
The drug formulation process involves combining an API with inactive ingredients to produce tablets, injections, or capsules. The goal is to create medicines that are safe, stable, and effective.
The following applications of XRF in pharmaceuticals manufacturing support end-to-end drug formulation, from ingredient selection to product release:
- Raw material qualifications – All raw materials must be tested and verified prior to drug formulation. XRF imaging supports the timely confirmation of raw material elements and tests for impurities.
- Excipient compatibility – Trace metals in excipients can cause API degradation. Manufacturers use XRF to ensure excipients are suitable for use with the required API.
- Process monitoring and control – XRF supports real-time process monitoring and control by screening samples for elemental residues in water during chemical mixing. It also integrates with Process Analytical Technology systems to provide real-time elemental monitoring.
- Drug uniformity and stability – XRF imaging supports elemental mapping, which shows API distribution across a tablet. It also monitors elemental stability over time, supporting efficacy and safety throughout a drug’s shelf life.
- Liquid and semi-solid development – Elemental analysis is critical in the formulation of creams, gels, solutions, and suspensions. X-ray fluorescence spectroscopy detects levels of metal impurities that could compromise the safety and shelf life of these drugs.
Pharmaceutical manufacturers use XRF in conjunction with other techniques like Inductively Coupled Plasma Spectroscopy. X-ray fluorescence spectroscopy devices are small, portable, and battery-powered. This enables fast on-site testing that manufacturers can build into their drug formulation process.
How XRF Supports Regulatory Compliance
The Medicines and Healthcare products Regulatory Agency (MHRA) is the governing body that ensures pharmaceutical companies meet safety, quality, and efficacy standards. It provides drug licenses, monitors clinical trials, and enforces regulatory compliance.
Elemental analysis is a critical step on the road to compliance. Pharmaceutical manufacturers must follow ICH Q3D guidelines, which provide a risk-based method for testing elemental impurities in drugs.
Steps in ICH Q3D compliance include:
- Identifying sources of elemental impurities and assessing the potential risks to patients
- Following permitted daily exposure limits for each element
- Implementing controls related to supplier qualification, material specifications, and testing
- Maintaining compliance across development, manufacturing, and post-approval changes
- Documenting risk assessments and evidencing control methods during inspections
Supporting ICH Q3D compliance is one of the most important applications of XRF in pharmaceuticals manufacturing. Through precise elemental analysis, X-ray fluorescence spectroscopy ensures drugs remain within the allowed limits for heavy metals.
XRF ensures APIs and other raw materials meet regulatory standards. The non-destructive nature of XRF also helps companies minimise toxic waste disposal and remain compliant with green chemistry initiatives.
Finally, many X-ray fluorescence systems contain software features that support digital recording. Companies use this during site audits and inspections.
Advancements in XRF Technology
XRF systems continue to evolve. As they do, pharmaceutical companies can refine their testing and manufacturing processes.
Machine Learning
Real-time data analysis in XRF technology is becoming more advanced with the help of machine learning. This technology detects patterns based on data and makes decisions without the need for manual programming.
Machine learning supports faster, more accurate element analysis. It also reduces human error during spectral interpretation.
Detector Upgrades
High-performance detectors support faster and more precise toxic element detection in XRF systems. They’re more sensitive than traditional equipment and allow for lower trace-level detection limits. Modern X-ray fluorescence spectrometers use technology like Silicon Drift Detectors. These tools offer high spectral resolution, micro-analysis, and rapid data collection.
3D Imaging
This advanced technique facilitates the mapping of elemental distribution throughout tablets and capsules. This is crucial for ensuring drug purity and release performance.
3D imaging detects counterfeit medicines by quickly analysing the density of the entire tablet, not just the surface area. This supports drug purity and patient safety.
Conclusion
In an industry where accuracy and safety are vital, X-ray fluorescence is a powerful tool for ensuring quality control and compliance. From elemental analysis to real-time monitoring, the applications of XRF in pharmaceuticals manufacturing are invaluable. As this technology advances, pharmaceutical companies will rely on XRF imaging to meet the growing demand for specialised drugs.
